Tizanidine hcl - Centrally Acting- Skeletal Muscle Relaxants- (Dec 1993)
Drug Name:
Tizanidine hcl - Centrally Acting- Skeletal Muscle Relaxants- (Dec 1993)
List Of Brands:
Indication Type Description:
Drug Interaction:
Potentiates hypotensive effect of antihypertensives. Increased CNS effects with alcohol and CNS depressants Increaed bradycardia with beta blockers and digoxin.
Increased serum conc. of tizanidine with CYP1A2 inhibitors eg. zileuton, ciprofloxacin and other fluroquinolones, antiarrhythmics, cimetidine, famotidine, oral contraceptives, aclovir, ticlopodine.
Decreased serum conc. of tizanidine with rifampicin. Use with caution with drugs that prolong QT interval
Indication:
Spasticity associated with multiple sclerosis
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Tizanidine HCl Muscle relaxant December 1993
2.Tizanidine SR Multiple sclerosis 06-02-2002
Adverse Reaction:
Drowsiness, fatigue, dizziness, Insomnia, headache, anxiety, Nausea, dryness of mouth, GI disturbances, Hypotension, bradycardia, Muscle pain and weakness, Transcient increase in serum transaminase, Hallucinations, Hepatitis
Contra-Indications:
Severe hepatic dysfunction
Special precautions: Hepatic or renal insufficiency. Children, Elderly Pregnancy, Lactation
Dosages/ Overdosage Etc:
Spasticity associated with multiple sclerosis
Dosage-
Initially 2mg daily as a single dose increasing to 2mg increments at no less than 3-4 days intervals Given in divided doses 3-4 times daily.
Other Information:
EVIDENCE BASED MEDICINE (April 2003)
Pain of Osteoarthiritis
Comparative effectiveness of various interventions
Beneficial
1. Systemic simple analgesics (eg paracetamol for short term pain relief, and improvement in function)
2. Systemic NSAIDs (short term pain relief and improvement in function)
3. Topical agents (short term pain relief)
Likely to be beneficial
1. Education, dietary advice,empowerment and support ( improved knowledge of disease and pain relief)
2. Physical support (pain relief and improvement in function)
KEY POINTS
1. There is no good evidence that NSAIDs were superior to simple analgesics such as paracetamol or to suggest that any one of the many available NSAIDs had greater efficacy in relieving pain of osteoarthritis.
2. One systematic review of randomised controlled trials has found that topical agents provide pain relief in patients with osteoarthritis and offer a non-toxic alternative to systemic drug treatment. However there is no evidence to indicate whether the prescribed agents were superior to less expensive, non-prescribtion drugs over the counter
(OTC) alternatives, or to other local treatments such as hot or cold packs.
Pregnancy and lactation:
Contraindicated for use during pregnancy and lactation Observe caution if required to be administered